Pulmonary pathology of infection by SARS-CoV-2, what we have learnt through post-mortem studies and pathophysiological considerations
Background: Since the declaration of Coronavirus Disease 2019 (COVID-19) caused the by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic, millions of people throughout the world have contracted the disease and more than 500,000 have died. While this terrible diseas...
Main Author: | Angela M Takano |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-06-01
|
Series: | Proceedings of Singapore Healthcare |
Online Access: | https://doi.org/10.1177/2010105820960495 |
Similar Items
-
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
by: Ivana Lazarevic, et al.
Published: (2021-06-01) -
RECURRENT STROKE: WHAT HAVE WE LEARNT?
by: EM Khoo, et al.
Published: (2007-01-01) -
40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?
by: Koy Chong Ng Kee Kwong, et al.
Published: (2021-03-01) -
Vaginal mesh: What lessons have we learnt?
by: Dudley Robinson, et al.
Published: (2020-10-01) -
Experimental Evolution of Legume Symbionts: What Have We Learnt?
by: Ginaini Grazielli Doin de Moura, et al.
Published: (2020-03-01)